MYCN and neuroblastoma: The results suggested that MTHFD1 maintained redox homeostasis in MYCN-amplified NB, and inhibiting MTHFD1 in tumor cells may weaken the resistance to oxidative stress, thus preventing the malignant progression of tumors.